Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Equine Arteritis Virus Uses Equine Cxcl16 As An Entry Receptor, Sanjay Sarkar, Lakshman Chelvarajan, Yun Young Go, Frank Cook, Sergey Artiushin, Shankar Mondal, Kelsi Anderson, John E. Eberth, Peter J. Timoney, Theodore S. Kalbfleisch, Ernest F. Bailey, Udeni B. R. Balasuriya
Equine Arteritis Virus Uses Equine Cxcl16 As An Entry Receptor, Sanjay Sarkar, Lakshman Chelvarajan, Yun Young Go, Frank Cook, Sergey Artiushin, Shankar Mondal, Kelsi Anderson, John E. Eberth, Peter J. Timoney, Theodore S. Kalbfleisch, Ernest F. Bailey, Udeni B. R. Balasuriya
Veterinary Science Faculty Publications
Previous studies in our laboratory have identified equine CXCL16 (EqCXCL16) to be a candidate molecule and possible cell entry receptor for equine arteritis virus (EAV). In horses, the CXCL16 gene is located on equine chromosome 11 (ECA11) and encodes a glycosylated, type I transmembrane protein with 247 amino acids. Stable transfection of HEK-293T cells with plasmid DNA carrying EqCXCL16 (HEK-EqCXCL16 cells) increased the proportion of the cell population permissive to EAV infection from < 3% to almost 100%. The increase in permissiveness was blocked either by transfection of HEK-EqCXCL16 cells with small interfering RNAs (siRNAs) directed against EqCXCL16 or by pretreatment with guinea pig polyclonal antibody against EqCXCL16 protein (Gp anti-EqCXCL16 pAb). Furthermore, using a virus overlay protein-binding assay (VOPBA) in combination with far-Western blotting, gradient-purified EAV particles were shown to bind directly to the EqCXCL16 protein in vitro. The binding of biotinylated virulent EAV strain Bucyrus at 4°C was significantly higher in HEK-EqCXCL16 cells than nontransfected HEK-293T cells. Finally, the results demonstrated …
Equine Protozoal Myeloencephalitis: An Updated Consensus Statement With A Focus On Parasite Biology, Diagnosis, Treatment, And Prevention, S. M. Reed, M. Furr, Daniel K. Howe, A. L. Johnson, R. J. Mackay, J. K. Morrow, N. Pusterla, S. Witonsky
Equine Protozoal Myeloencephalitis: An Updated Consensus Statement With A Focus On Parasite Biology, Diagnosis, Treatment, And Prevention, S. M. Reed, M. Furr, Daniel K. Howe, A. L. Johnson, R. J. Mackay, J. K. Morrow, N. Pusterla, S. Witonsky
Veterinary Science Faculty Publications
Equine protozoal myeloencephalitis (EPM) remains an important neurologic disease of horses. There are no pathognomonic clinical signs for the disease. Affected horses can have focal or multifocal central nervous system (CNS) disease. EPM can be difficult to diagnose antemortem. It is caused by either of 2 parasites, Sarcocystis neurona and Neospora hughesi, with much less known about N. hughesi. Although risk factors such as transport stress and breed and age correlations have been identified, biologic factors such as genetic predispositions of individual animals, and parasite-specific factors such as strain differences in virulence, remain largely undetermined. This consensus statement …